SCIENTIFIC EVIDENCE

A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Zhang R, Tang L, Wang Y, Tian Y, Wu S, Zhou B, Dong C, Zhao B, Yang Y, Xie D, Yang L.

Publication Overview

Key findings, Countstar context, and access to the original paper.

2023

Cancer Research

Immunology

No items found.

Key Finding

Here, this work reports that a simple dendrimer polypeptide (KK2DP7) nanoparticle enhances the immune efficacy of an OVA/neoantigen-based vaccine. Thus, KK2DP7-based cancer vaccines alone or in combination with immune checkpoint blockade therapies to treat tumors or postoperative tumor recurrence are a powerful strategy to enhance antitumor immunity.

Countstar Connection

The researchers measured migrated or invaded cell numbers in the study's cell samples with Countstar (model not specified) during migration assessment in the 2023 Advanced science study.

Stay Connected to

Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.

Meet us online